GB0221561D0 - ADP assay - Google Patents

ADP assay

Info

Publication number
GB0221561D0
GB0221561D0 GBGB0221561.4A GB0221561A GB0221561D0 GB 0221561 D0 GB0221561 D0 GB 0221561D0 GB 0221561 A GB0221561 A GB 0221561A GB 0221561 D0 GB0221561 D0 GB 0221561D0
Authority
GB
United Kingdom
Prior art keywords
adp assay
adp
assay
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0221561.4A
Other versions
GB2394286A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
INNOVAB Ltd
Original Assignee
INNOVAB Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by INNOVAB Ltd filed Critical INNOVAB Ltd
Priority to GB0221561A priority Critical patent/GB2394286A/en
Publication of GB0221561D0 publication Critical patent/GB0221561D0/en
Priority to AU2003264887A priority patent/AU2003264887A1/en
Priority to PCT/GB2003/004015 priority patent/WO2004027421A2/en
Publication of GB2394286A publication Critical patent/GB2394286A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/008—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions for determining co-enzymes or co-factors, e.g. NAD, ATP
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/527—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving lyase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/66—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving luciferase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G01N33/5735—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes co-enzymes or co-factors, e.g. NAD, ATP

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Oncology (AREA)
GB0221561A 2002-09-17 2002-09-17 An assay for adp using an adp binding protein Withdrawn GB2394286A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB0221561A GB2394286A (en) 2002-09-17 2002-09-17 An assay for adp using an adp binding protein
AU2003264887A AU2003264887A1 (en) 2002-09-17 2003-09-17 Adp assay
PCT/GB2003/004015 WO2004027421A2 (en) 2002-09-17 2003-09-17 Adp assay

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0221561A GB2394286A (en) 2002-09-17 2002-09-17 An assay for adp using an adp binding protein

Publications (2)

Publication Number Publication Date
GB0221561D0 true GB0221561D0 (en) 2002-10-23
GB2394286A GB2394286A (en) 2004-04-21

Family

ID=9944237

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0221561A Withdrawn GB2394286A (en) 2002-09-17 2002-09-17 An assay for adp using an adp binding protein

Country Status (3)

Country Link
AU (1) AU2003264887A1 (en)
GB (1) GB2394286A (en)
WO (1) WO2004027421A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111850065A (en) * 2020-07-29 2020-10-30 江南大学 Method for assisting whole-cell transformation to synthesize L-asparagine

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7355010B2 (en) 2003-01-30 2008-04-08 Bellbrook Labs, Llc Assay method for group transfer reactions
US8088897B2 (en) 2003-01-30 2012-01-03 BellBrook Labs, Inc. Assay method for group transfer reactions
JP2006519013A (en) 2003-01-30 2006-08-24 ベル ブルック ラブズ リミテッド ライアビリティ カンパニー Method for assaying group transfer reaction
WO2006127008A1 (en) * 2005-05-26 2006-11-30 Bellbrook Labs, Llc Assay method for group transfer reactions
WO2010011607A1 (en) * 2008-07-22 2010-01-28 Promega Corporation Adp detection based luminescent phosphotransferase or atp hydrolase assay
GB0817166D0 (en) * 2008-09-19 2008-10-29 Medical Res Council Sensor
EP3204509B1 (en) 2014-10-08 2019-07-10 Promega Corporation Bioluminescent succinate detection assay

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5531020A (en) * 1978-08-26 1980-03-05 Asahi Chem Ind Co Ltd Preparation of antiserum for coenzyme
US6946244B2 (en) * 2001-08-07 2005-09-20 Euroscreen, S.A. Methods of identifying a ligand, an agonist, and an antagonist of G protein coupled receptor GPR86 (P2Y13)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111850065A (en) * 2020-07-29 2020-10-30 江南大学 Method for assisting whole-cell transformation to synthesize L-asparagine

Also Published As

Publication number Publication date
WO2004027421A3 (en) 2004-06-17
WO2004027421A2 (en) 2004-04-01
GB2394286A (en) 2004-04-21
AU2003264887A1 (en) 2004-04-08

Similar Documents

Publication Publication Date Title
GB0212391D0 (en) Assay
GB0204232D0 (en) Assay
GB0221561D0 (en) ADP assay
GB0229807D0 (en) Assay
GB0221915D0 (en) Assay
GB0325483D0 (en) Assay
GB0229582D0 (en) Novel assay
GB0302740D0 (en) Assay
GB0222627D0 (en) Assay
GB0202776D0 (en) Assay
GB0214947D0 (en) Assay
GB0223960D0 (en) Assay methods
GB0311228D0 (en) Assay
GB0312403D0 (en) Assay
GB0201039D0 (en) Assay
GB0218222D0 (en) ADP assay
GB0225282D0 (en) assay
GB0327143D0 (en) Assay
GB0318551D0 (en) ADP assay
GB0202276D0 (en) Assays
GB0228674D0 (en) Assay
GB0213444D0 (en) Assay
GB0225550D0 (en) Assay
GB0223667D0 (en) Assay
GB0230342D0 (en) Assay

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)